Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesse D Bloom

Showing results (241-250 of 253) with videos related to

Pageof 26
Sort By:
Biorxiv : the Preprint Server for Biology|January 25, 2022
Selection analysis identifies unusual clustered mutational changes in Omicron lineage BA.1 that likely impact Spike functionDarren P Martin, Spyros Lytras, Alexander G Lucaci, et al.
Nature Medicine|November 13, 2023
Dynamics and durability of HIV-1 neutralization are determined by viral replicationPhilipp Schommers, Dae Sung Kim, Maike Schlotz, et al.
Nature|May 8, 2024
Computationally restoring the potency of a clinical antibody against OmicronThomas A Desautels, Kathryn T Arrildt, Adam T Zemla, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
Profiling a large HIV-1 elite neutralizer cohort reveals remarkable CD4bs bNAb for HIV-1 prevention and therapyLutz Gieselmann, Andrew T DeLaitsch, Malena Rohde, et al.
Biorxiv : the Preprint Server for Biology|April 14, 2021
Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escapeTyler N Starr, Nadine Czudnochowski, Fabrizia Zatta, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2021
Multivalent designed proteins protect against SARS-CoV-2 variants of concernAndrew C Hunt, James Brett Case, Young-Jun Park, et al.
Nature Immunology|October 6, 2025
Profiling of HIV-1 elite neutralizer cohort reveals a CD4bs bnAb for HIV-1 prevention and therapyLutz Gieselmann, Andrew T DeLaitsch, Malena Rohde, et al.
Nature|July 19, 2021
Broad sarbecovirus neutralization by a human monoclonal antibodyM Alejandra Tortorici, Nadine Czudnochowski, Tyler N Starr, et al.
Biorxiv : the Preprint Server for Biology|April 14, 2021
Structural basis for broad sarbecovirus neutralization by a human monoclonal antibodyM Alejandra Tortorici, Nadine Czudnochowski, Tyler N Starr, et al.
Science Translational Medicine|April 12, 2022
Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in miceAndrew C Hunt, James Brett Case, Young-Jun Park, et al.
Pageof 26

Showing results (241-250 of 253) with videos related to

Sort By:
Pageof 26
Biorxiv : the Preprint Server for Biology|January 25, 2022
Selection analysis identifies unusual clustered mutational changes in Omicron lineage BA.1 that likely impact Spike functionDarren P Martin, Spyros Lytras, Alexander G Lucaci, et al.
Nature Medicine|November 13, 2023
Dynamics and durability of HIV-1 neutralization are determined by viral replicationPhilipp Schommers, Dae Sung Kim, Maike Schlotz, et al.
Nature|May 8, 2024
Computationally restoring the potency of a clinical antibody against OmicronThomas A Desautels, Kathryn T Arrildt, Adam T Zemla, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
Profiling a large HIV-1 elite neutralizer cohort reveals remarkable CD4bs bNAb for HIV-1 prevention and therapyLutz Gieselmann, Andrew T DeLaitsch, Malena Rohde, et al.
Biorxiv : the Preprint Server for Biology|April 14, 2021
Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escapeTyler N Starr, Nadine Czudnochowski, Fabrizia Zatta, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2021
Multivalent designed proteins protect against SARS-CoV-2 variants of concernAndrew C Hunt, James Brett Case, Young-Jun Park, et al.
Nature Immunology|October 6, 2025
Profiling of HIV-1 elite neutralizer cohort reveals a CD4bs bnAb for HIV-1 prevention and therapyLutz Gieselmann, Andrew T DeLaitsch, Malena Rohde, et al.
Nature|July 19, 2021
Broad sarbecovirus neutralization by a human monoclonal antibodyM Alejandra Tortorici, Nadine Czudnochowski, Tyler N Starr, et al.
Biorxiv : the Preprint Server for Biology|April 14, 2021
Structural basis for broad sarbecovirus neutralization by a human monoclonal antibodyM Alejandra Tortorici, Nadine Czudnochowski, Tyler N Starr, et al.
Science Translational Medicine|April 12, 2022
Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in miceAndrew C Hunt, James Brett Case, Young-Jun Park, et al.
Pageof 26